The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Preferential risk of HPV16 for squamous cell carcinoma and of HPV18 for adenocarcinoma of the cervix compared to women with normal cytology in The Netherlands
Open accessAbstract
We present the type-distribution of high-risk human papillomavirus (HPV) types in women with normal cytology (n=1467), adenocarcinoma in situ (ACIS) (n=61), adenocarcinoma (n=70), and squamous cell carcinoma (SCC) (n=83). Cervical adenocarcinoma and ACIS were significantly more frequently associated with HPV18 (OR(MH) 15.0; 95% CI 8.6-26.1 and 21.8; 95% CI 11.9-39.8, respectively) than normal cytology. Human papillomavirus16 was only associated with adenocarcinoma and ACIS after exclusion of HPV18-positive cases (OR(MH) 6.6; 95% CI 2.8-16.0 and 9.4; 95% CI 2.8-31.2, respectively). For SCC, HPV16 prevalence was elevated (OR(MH) 7.0; 95% CI 3.9-12.4) compared to cases with normal cytology, and HPV18 prevalence was only increased after exclusion of HPV16-positive cases (OR(MH) 4.3; 95% CI 1.6-11.6). These results suggest that HPV18 is mainly a risk factor for the development of adenocarcinoma whereas HPV16 is associated with both SCC and adenocarcinoma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The 2001 Bethesda System<SUBTITLE>Terminology for Reporting Results of Cervical Cytology</SUBTITLE>
Solomon, D. (2002) · JAMA · doi:10.1001/jama.287.16.2114 · Cited by 3,104
Management of women who test positive for high-risk types of human papillomavirus: the HART study
Cuzick, J., Szarewski, A., Cubie, H., Hulman, G., Kitchener, H., Luesley, D., McGoogan, E., Menon, U., Terry, G., Edwards, R., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14955-0 · Cited by 510 · cited 2×
“Testing for hrHPV types combined with cervical cytology becomes increasingly attractive as data accumulate that a combined test increases the efficacy of cervical screening programmes and triage policies for women with both equivocal and normal cervical smears (”
Background
Cited by
Human papillomavirus and cervical cancer
Schiffman, M., Castle, P. E., Jeronimo, J., Rodriguez, A. C., & Wacholder, S. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61416-0 · Cited by 2,985
Cervical Cancer Prevention—Cervical Screening: Science in Evolution
Safaeian, M., Solomon, D., & Castle, P. E. (2007) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2007.09.004 · Cited by 265
Activation of the Enhancer of Zeste Homologue 2 Gene by the Human Papillomavirus E7 Oncoprotein
Holland, D., Hoppe-Seyler, K., Schuller, B., Lohrey, C., Maroldt, J., Dürst, M., & Hoppe-Seyler, F. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1134 · Cited by 99
Metadata
- Authors
- Bulk, S., Berkhof, J., Bulkmans, N. W. J., Zielinski, G. D., Rozendaal, L., van Kemenade, F. J., Snijders, P. J. F., & Meijer, C. J. L. M.
- Venue
- British Journal of Cancer
- Published
- 2005-12-13
- Volume
- 94
- Issue
- 1
- Pages
- 171-175
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W2075154637
- Cited by
- 163
- References
- 2
- FWCI
- 8.29
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Preferential risk of HPV16 for squamous cell carcinoma and of HPV18 for adenocarcinoma of the cervix compared to women with normal cytology in The Netherlands. https://app.cochat.ai/papers/10.1038/sj.bjc.6602915
- The paper
- Bulk, S., Berkhof, J., Bulkmans, N. W. J., Zielinski, G. D., Rozendaal, L., van Kemenade, F. J., Snijders, P. J. F., & Meijer, C. J. L. M. (2006). Preferential risk of HPV16 for squamous cell carcinoma and of HPV18 for adenocarcinoma of the cervix compared to women with normal cytology in The Netherlands. British Journal of Cancer. https://doi.org/10.1038/sj.bjc.6602915
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.